R Winn - Concepedia

Author

R Winn

The University of Texas MD Anderson Cancer Center

Also Known As

R J Winn, R Winn, R. J. Winn, R.J. Winn, Rodger J. Winn, Roger J. Winn, Roger Winn

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center

About

R Winn is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	265
2	Health Sciences	2	2	150
3	Education	1	1	18
4	Counseling	1	1	18
5	Educational Program Development	1	1	18

R Winn

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Phase II Study of Taxol in Patients With Untreated Advanced Non-Small-Cell Lung Cancer William K. Murphy, Frank V. Fossella, R Winn, JNCI Journal of the National Cancer Institute	1993	430
Randomized Phase III Intergroup Trial of Isotretinoin to Prevent Second Primary Tumors in Stage I Non-Small-Cell Lung Cancer Scott M. Lippman, J. Jack Lee, Daniel D. Karp, JNCI Journal of the National Cancer Institute	2001	319
Transportation as a barrier to cancer treatment. Jeffrey J. Guidry, L A Aday, Dongyu Zhang, PubMed	1997	195
Regression of Oral Leukoplakia With -Tocopherol: A Community Clinical Oncology Program Chemoprevention Study Steven E. Benner, R Winn, Scott M. Lippman, JNCI Journal of the National Cancer Institute	1993	140
Phase II study of fluorouracil and recombinant interferon alfa-2a in previously untreated advanced colorectal carcinoma. Richard Pazdur, Jaffer A. Ajani, Yehuda Z. Patt, Journal of Clinical Oncology ImmunologyPathologyPhase Ii StudyPharmacotherapyMetronomic Chemotherapy	1990	140
Benzo[a]pyrene Diol Epoxide and Bleomycin Sensitivity and Susceptibility to Cancer of Upper Aerodigestive Tract Xifeng Wu, Jun Gu, Waun Ki Hong, JNCI Journal of the National Cancer Institute	1998	66
Use of hematopoietic colony-stimulating factors: the American Society of Clinical Oncology survey. The Health Services Research Committee of the American Society of Clinical Oncology. Charles L. Bennett, Thomas J. Smith, John Weeks, Journal of Clinical Oncology	1996	65
Randomized phase 2 trial of ketoconazole and ketoconazole/doxorubicin in androgen independent prostate cancer Randall E. Millikan, Luis Báez, Tarit K. Banerjee, Urologic Oncology Seminars and Original Investigations UrologyGenitourinary CancerMedicinePharmacologyPharmacotherapy	2001	59
Phase II trial of 9-aminocamptothecin administered as a 72-hour continuous infusion in metastatic colorectal carcinoma. Richard Pazdur, Enrique Díaz-Cantón, Wenners Ballard, Journal of Clinical Oncology	1997	45
Phase II evaluation of iproplatin in patients with advanced gastric and pancreatic cancer. Hubbard Kp, Richard Pazdur, Ajani Ja, PubMed Phase Ii EvaluationPancreatic CancerGastrointestinal OncologyMedicinePharmacology	1992	20

Page 1